Acquisition Of Compound BCR-ABL1 Alleles As A Mechanism Of Resistance To Ponatinib In Chronic Myeloid Leukemia

被引：0
|
作者：
Gibbons, Don L.
Pricl, Sabrina
Posocco, Paola
Laurini, Erik
Fermeglia, Maurizio
Talpaz, Moshe
Cortes, Jorge E.
Donato, Nicholas J.
Quintas-Cardama, Alfonso
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.853.853
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
853
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
    Smith, Brittany M.
    Brewer, Diana
    Druker, Brian J.
    Braun, Theodore P.
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1707 - 1711
  • [22] Absolute quantification of BCR-ABL1 fusion transcripts in pediatric chronic myeloid leukemia
    Tang, Yanjing
    Wei, Xiaoyuan
    Chen, Jing
    Du, Yunzhi
    Chu, Huiling
    Mao, Louise
    Chen, Jun
    Xu, Qing
    Tang, Jingyan
    Shen, Shuhong
    Mao, Mao
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2216 - 2218
  • [23] Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Langabeer, Stephen E.
    McCarron, Sarah L.
    Haslam, Karl
    Preston, Lisa
    CLINICAL LABORATORY, 2016, 62 (05) : 975 - 976
  • [24] Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
    Malik, Sara
    Hassan, Shahzeb
    Eskazan, Ahmet Emre
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (11) : 975 - 978
  • [25] Prognostic Significance of Transcript-Type BCR-ABL1 in Chronic Myeloid Leukemia
    Molica, Matteo
    Abruzzese, Elisabetta
    Breccia, Massimo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [26] Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients
    Arun, A. K.
    Senthamizhselvi, A.
    Mani, S.
    Vinodhini, K.
    Janet, N. B.
    Lakshmi, K. M.
    Abraham, A.
    George, B.
    Srivastava, A.
    Srivastava, V. M.
    Mathews, V.
    Balasubramanian, P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (03) : 235 - 242
  • [27] Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia patients
    Martinez-Castillo, Macario
    Tovar, Hugo
    Gomez-Romero, Laura
    Olarte-Carrillo, Irma
    Martinez-Tovar, Adolfo
    Hernandez Zavala, Araceli
    Cordova Alarcon, Emilio Joaquin
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 268 - 268
  • [28] GENETIC MUTATIONS OUTSIDE BCR-ABL1 DETERMINING TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKEMIA
    Aref, Salah
    Abdalla, Nada
    Muller, Martin
    El Sharaway, Solofa
    Aziz, Sherin Abdel
    Sauselle, Sussane
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 17 - 17
  • [29] Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Kino, Toshiki
    Sakai, Kazuko
    Itoh, Tatsuki
    Imano, Motohiro
    Nakayama, Takashi
    Nishio, Kazuto
    Satou, Takao
    Nishida, Shozo
    ONCOTARGET, 2017, 8 (24) : 38717 - 38730
  • [30] BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
    Amarante-Mendes, Gustavo P.
    Rana, Aamir
    Datoguia, Tarcila Santos
    Hamerschlak, Nelson
    Brumatti, Gabriela
    PHARMACEUTICS, 2022, 14 (01)
12345